Regulation of Protein Synthesis and Erythropoiesis
Regulation of Protein Synthesis and Erythropoiesis
批准号:
7168818
负责人:
JANE-JANE CHEN
金额:
$36.88万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-01-01 至 2008-11-30
关键词:
AccountingAnabolismAnimalsApoptosisApoptosis RegulatorBiochemicalBiological AssayBiologyBlood Cell CountBone MarrowCellsChargeConditionCultured CellsDietDiseaseElectronsEmbryoErythroblastsErythrocytesErythroidErythroid CellsErythroid HyperplasiaErythroid Progenitor CellsErythropoiesisEukaryotic Initiation Factor-2Fetal LiverFundingGenerationsGenesGlobinHalf-LifeHemeHemeproteinsHemoglobinHepatocyteHumanIronKnockout MiceLeadMediatingMethodsMicroscopicMolecularMusPatientsPersonal SatisfactionPhosphorylationPhosphotransferasesPhysiologicalPorphyriasProcessProductionProsthesisProtein BiosynthesisProtein KinaseProteinsProtoporphyrinsRecombinant DNARecyclingRegulationResearch DesignReticulocytesRetroviridaeRoleSeveritiesSiteSpleenStressSymptomsTechniquesTestingThalassemiaTranslational RegulationWestern Blottingdomain mappingerythroid differentiationferrochelataseheme aheme biosynthesisinhibitor/antagonistmouse modelmutantprecursor cellprogenitortranscription factor CHOP
中文摘要
我们的长期目标是有助于理解血红蛋白合成的调节和
在正常和异常的血液学条件下的红系分化,特别强调
血红素和蛋白质合成在这些过程中的作用。完整网织红细胞的蛋白质合成及其功能
裂解产物依赖于血红素的可用性。血红素是血红蛋白的修饰基,
红细胞及其晚期前体细胞中的主要蛋白质。生化研究表明
在缺Heine或缺铁的情况下,蛋白质合成在以下水平受到抑制
由于血红素调节的翻译抑制物(HRI)的激活而启动。HRI是一种受血红素调控的
使真核生物起始因子2(EIF2a)的ct亚单位磷酸化的蛋白激酶。磷酸化
Eif2的ct亚基在翻译启动过程中会损害其循环,导致蛋白质的停止。
综合。研究设计为:(1)阐明HRI调控红色的分子机制
血细胞生成,(2)评估HRI在红细胞疾病中的保护作用,以及(3)
阐明HRI应激激活的分子机制。要采用的方法是
转基因小鼠的产生、血液学分析、组织学和电子显微镜观察
红系祖细胞集落培养检测、蛋白印迹分析和蛋白激酶
检测、细胞培养、小鼠胚胎表型检测、重组DNA技术。我们最近
研究表明,HRI不仅是珠蛋白合成所必需的,也是Heine生物合成所必需的。HRI也是
对地中海贫血和红细胞生成性原畸形症小鼠的生存很重要。我们建议的研究
可能导致HRI在治疗人类红细胞病患者方面的潜在应用。
英文摘要
Our long-term objective is to contribute to the understanding of the regulation of hemoglobin synthesis and
erythroid differentiation in normal and abnormal hematological conditions, with particular emphasis on the
roles of heme and protein synthesis in these processes. Protein synthesis in intact reticulocytes and their
lysates is dependent on the availability of heme. Heme serves as the prosthetic group of the hemoglobin, the
predominant protein in red blood cell (RBC) and its late precursor cells. Biochemical studies have shown
that, under conditions of heine-deficiency or iron-deficiency, protein synthesis is inhibited at the level of
initiation due to the activation of the heme-regulated translational inhibitor (HRI). HRI is a heme-regulated
protein kinasc that phosphorylates the ct-subunit of eukaryotic initiation factor 2 (eIF2a). Phosphorylation of
the ct-subunit of eIF2 impairs its recycling in translational initiation and results in the cessation of protein
synthesis. The research designs are (1) To Elucidate the Molecular Mechanism by which HRI Regulates Red
Blood Cell Production, (2) To Assess the Protective Role of HRI in Red Blood Cell Disorders, and (3) To
Delineate the Molecular Mechanism of Stress-Activation of HRI. The methods to be employed are the
generation of genetically modified mice, hematological analysis, histological and electron microscopic
examinations, colony culture assays for erythroid progenitors, Western-blot analysis and protein kinase
assays, cell culture, phenotypic examination of mouse embryos, recombinant DNA techniques. Our recent
study indicate that HRI is not only necessary for globin synthesis, but also for heine biosynthesis. HRI is also
important for the survival of mice with thalassemia and erythropoietic protoporphria. Our proposed study
may lead to potential application of HRI in treating human patients with red cell diseases.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.humpath.2007.10.021
发表时间:
2008-06
期刊:
Human pathology
影响因子:
3.3
作者:
[I. Rosenwald;L. Koifman;L. Savas;Jane-Jane Chen-Jane;B. Woda;M. Kadin]
通讯作者:
I. Rosenwald;L. Koifman;L. Savas;Jane-Jane Chen-Jane;B. Woda;M. Kadin
Regulation of hemoglobin synthesis and proliferation of differentiating erythroid cells by heme-regulated eIF-2alpha kinase.
通过血红素调节的 eIF-2α 激酶调节血红蛋白合成和分化红细胞增殖。
DOI:
--
发表时间:
2000
期刊:
Blood
影响因子:
20.3
作者:
[Crosby,JS, Chefalo,PJ, Yeh,I, Ying,S, London,IM, Leboulch,P, Chen,JJ]
通讯作者:
Chen,JJ
Molecular cloning and characterization of the promoter of mouse heme-regulated eIF2alpha kinase.
小鼠血红素调节的 eIF2α 激酶启动子的分子克隆和表征。
DOI:
10.1016/s0167-4781(01)00281-0
发表时间:
2002
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
[Lu,Linrong, Chen,JaneJane]
通讯作者:
Chen,JaneJane
DOI:
10.1111/j.1365-2141.2008.07293.x
发表时间:
2008-10
期刊:
British journal of haematology
影响因子:
6.5
作者:
[Liu S, Bhattacharya S, Han A, Suragani RN, Zhao W, Fry RC, Chen JJ]
通讯作者:
Chen JJ
Effect of interferon on protein translation during growth stages of 3T3 cells.
干扰素对 3T3 细胞生长阶段蛋白质翻译的影响。
DOI:
10.1006/abbi.1996.0078
发表时间:
1996
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Petryshyn,R, Chen,JJ, Danley,L, Matts,RL]
通讯作者:
Matts,RL
共 15 条
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and Erythropoiesis
-
批准号:7863731
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:8703304
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and Erythropoiesis
-
批准号:8279410
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:9243242
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:8729681
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesis
-
批准号:8829233
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and Erythropoiesis
-
批准号:8110587
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:8099953
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2010
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:7903778
-
项目类别:
-
资助金额:$8.91万
-
财政年份:2009
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:7674587
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2008
-
负责人:JANE-JANE CHEN
-
依托单位:
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for Thalassemia
-
批准号:7470479
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2008
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:6350684
-
项目类别:
-
资助金额:$21.56万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:2446303
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:6150559
-
项目类别:
-
资助金额:$20.93万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
STRUCTURE/FUNCTION OF HEME REGULATED ELF-2ALPHA KINASE
-
批准号:2872246
-
项目类别:
-
资助金额:$20.68万
-
财政年份:1998
-
负责人:JANE-JANE CHEN
-
依托单位:
REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS
-
批准号:2136998
-
项目类别:
-
资助金额:$29.9万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS
-
批准号:6176508
-
项目类别:
-
资助金额:$30.38万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESIS
-
批准号:2900122
-
项目类别:
-
资助金额:$29.49万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
Regulation of Protein Synthesis and Erythropoiesis
-
批准号:6688995
-
项目类别:
-
资助金额:$38.89万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
Regulation of Protein Synthesis and Erythropoiesis
-
批准号:6829082
-
项目类别:
-
资助金额:$38.89万
-
财政年份:1979
-
负责人:JANE-JANE CHEN
-
依托单位:
海外基金